{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:28:51Z","timestamp":1794025731393,"version":"4.8.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22275081, 82372117, 52303381"],"award-info":[{"award-number":["22275081, 82372117, 52303381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010464"],"award-info":[{"award-number":["2024A1515010464"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69420-1","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:36:18Z","timestamp":1770730578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Granulomas microenvironment-guided sono-immunotherapy to treat and prevent recurrence of tuberculosis"],"prefix":"10.1038","volume":"17","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zining","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixian","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2665-5932","authenticated-orcid":false,"given":"Pingqiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0079-8625","authenticated-orcid":false,"given":"Shasha","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-0545","authenticated-orcid":false,"given":"Yupeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8381-7440","authenticated-orcid":false,"given":"Dongfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"69420_CR1","unstructured":"Global Tuberculosis Report 2024 (World Health Organization, 2024)."},{"key":"69420_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104173","volume":"82","author":"CLR van Doorn","year":"2022","unstructured":"van Doorn, C. L. R. et al. Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment. EBioMedicine 82, 104173 (2022).","journal-title":"EBioMedicine"},{"key":"69420_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.chom.2024.04.019","volume":"32","author":"S Helaine","year":"2024","unstructured":"Helaine, S., Conlon, B. P., Davis, K. M. & Russell, D. G. Host stress drives tolerance and persistence: the bane of anti-microbial therapeutics. Cell Host Microbe 32, 852\u2013862 (2024).","journal-title":"Cell Host Microbe"},{"key":"69420_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nri3211","volume":"12","author":"L Ramakrishnan","year":"2012","unstructured":"Ramakrishnan, L. Revisiting the role of the granuloma in tuberculosis. Nat. Rev. Immunol. 12, 352\u2013366 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"69420_CR5","doi-asserted-by":"crossref","unstructured":"Ca\u00f1o-Mu\u00f1iz, S., Anthony, R., Niemann, S. & Alffenaar, J. C. New approaches and therapeutic options for Mycobacterium tuberculosis in a dormant state. Clin. Microbiol. Rev. 31, e00060\u201317 (2018).","DOI":"10.1128\/CMR.00060-17"},{"key":"69420_CR6","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM199910143411602","volume":"341","author":"A van Rie","year":"1999","unstructured":"van Rie, A. et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341, 1174\u20131179 (1999).","journal-title":"N. Engl. J. Med."},{"key":"69420_CR7","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","volume":"171","author":"S Verver","year":"2005","unstructured":"Verver, S. et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care Med. 171, 1430\u20131435 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"69420_CR8","doi-asserted-by":"publisher","first-page":"e0268290","DOI":"10.1371\/journal.pone.0268290","volume":"17","author":"HM Youn","year":"2022","unstructured":"Youn, H. M. et al. Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLoS ONE 17, e0268290 (2022).","journal-title":"PLoS ONE"},{"key":"69420_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39300-z","volume":"14","author":"KA Abrahams","year":"2023","unstructured":"Abrahams, K. A. et al. DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid. Nat. Commun. 14, 3828 (2023).","journal-title":"Nat. Commun."},{"key":"69420_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41577-022-00734-z","volume":"23","author":"RS Wallis","year":"2023","unstructured":"Wallis, R. S., O\u2019Garra, A., Sher, A. & Wack, A. Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nat. Rev. Immunol. 23, 121\u2013133 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"69420_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.vaccine.2019.10.072","volume":"38","author":"J Vekemans","year":"2020","unstructured":"Vekemans, J. et al. Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: key considerations from World Health Organization consultations. Vaccine 38, 135\u2013142 (2020).","journal-title":"Vaccine"},{"key":"69420_CR12","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41565-024-01618-0","volume":"19","author":"B Li","year":"2024","unstructured":"Li, B. et al. Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles. Nat. Nanotechnol. 19, 834\u2013845 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"69420_CR13","doi-asserted-by":"publisher","first-page":"2406143","DOI":"10.1002\/adma.202406143","volume":"36","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. NIR-II AIE luminogen-based erythrocyte-like nanoparticles with granuloma-targeting and self-oxygenation characteristics for combined phototherapy of tuberculosis. Adv. Mater. 36, 2406143 (2024).","journal-title":"Adv. Mater."},{"key":"69420_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bsheal.2022.03.013","volume":"4","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Biosafety materials for tuberculosis treatment. Biosaf. Health. 4, 258\u2013268 (2022).","journal-title":"Biosaf. Health."},{"key":"69420_CR15","doi-asserted-by":"publisher","first-page":"e0008823","DOI":"10.1128\/cmr.00088-23","volume":"36","author":"SK Suman","year":"2023","unstructured":"Suman, S. K., Chandrasekaran, N. & Priya Doss, C. G. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments. Clin. Microbiol. Rev. 36, e0008823 (2023).","journal-title":"Clin. Microbiol. Rev."},{"key":"69420_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jinf.2023.09.004","volume":"87","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Single-cell RNA-sequencing reveals heterogeneity and intercellular crosstalk in human tuberculosis lung. J. Infect. 87, 373\u2013384 (2023).","journal-title":"J. Infect."},{"key":"69420_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.immuni.2022.04.004","volume":"55","author":"HP Gideon","year":"2022","unstructured":"Gideon, H. P. et al. Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. Immunity 55, 827\u2013846.e810 (2022).","journal-title":"Immunity"},{"key":"69420_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/infdis\/jiv447","volume":"213","author":"JM Cliff","year":"2016","unstructured":"Cliff, J. M. et al. Excessive cytolytic responses predict tuberculosis relapse after apparently successful treatment. J. Infect. Dis. 213, 485\u2013495 (2016).","journal-title":"J. Infect. Dis."},{"key":"69420_CR19","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41423-020-0502-z","volume":"17","author":"Q Chai","year":"2020","unstructured":"Chai, Q., Wang, L., Liu, C. H. & Ge, B. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis. Cell. Mol. Immunol. 17, 901\u2013913 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"69420_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41590-021-01121-x","volume":"23","author":"EF McCaffrey","year":"2022","unstructured":"McCaffrey, E. F. et al. The immunoregulatory landscape of human tuberculosis granulomas. Nat. Immunol. 23, 318\u2013329 (2022).","journal-title":"Nat. Immunol."},{"key":"69420_CR21","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1182\/blood.V99.5.1699","volume":"99","author":"Y Nagai","year":"2002","unstructured":"Nagai, Y. et al. Requirement for MD-1 in cell surface expression of RP105\/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99, 1699\u20131705 (2002).","journal-title":"Blood"},{"key":"69420_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.419","volume":"5","author":"L Zhuang","year":"2024","unstructured":"Zhuang, L., Yang, L., Li, L., Ye, Z. & Gong, W. Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention. MedComm 5, e419 (2024).","journal-title":"MedComm"},{"key":"69420_CR23","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1002\/smll.201500937","volume":"11","author":"AA Hwang","year":"2015","unstructured":"Hwang, A. A. et al. pH-responsive isoniazid-loaded nanoparticles markedly improve tuberculosis treatment in mice. Small 11, 5066\u20135078 (2015).","journal-title":"Small"},{"key":"69420_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1473-3099(18)30110-5","volume":"18","author":"S Tiberi","year":"2018","unstructured":"Tiberi, S. et al. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect. Dis. 18, 183\u2013198 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"69420_CR25","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1039\/D0CS01051K","volume":"52","author":"M Piksa","year":"2023","unstructured":"Piksa, M. et al. The role of the light source in antimicrobial photodynamic therapy. Chem. Soc. Rev. 52, 1697\u20131722 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"69420_CR26","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1039\/C9CS00648F","volume":"49","author":"S Son","year":"2020","unstructured":"Son, S. et al. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem. Soc. Rev. 49, 3244\u20133261 (2020).","journal-title":"Chem. Soc. Rev."},{"key":"69420_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100949","volume":"35","author":"J Ouyang","year":"2020","unstructured":"Ouyang, J. et al. Ultrasound mediated therapy: Recent progress and challenges in nanoscience. Nano Today 35, 100949 (2020).","journal-title":"Nano Today"},{"key":"69420_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42509-7","volume":"14","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity. Nat. Commun. 14, 6973 (2023).","journal-title":"Nat. Commun."},{"key":"69420_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31551-6","volume":"13","author":"J Li","year":"2022","unstructured":"Li, J. et al. Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodulatory nanoparticles. Nat. Commun. 13, 4032 (2022).","journal-title":"Nat. Commun."},{"key":"69420_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1039\/C8CS00001H","volume":"48","author":"J Li","year":"2019","unstructured":"Li, J. & Pu, K. Development of organic semiconducting materials for deep-tissue optical imaging, phototherapy and photoactivation. Chem. Soc. Rev. 48, 38\u201371 (2019).","journal-title":"Chem. Soc. Rev."},{"key":"69420_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nnano.2013.302","volume":"9","author":"K Pu","year":"2014","unstructured":"Pu, K. et al. Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice. Nat. Nanotechnol. 9, 233\u2013239 (2014).","journal-title":"Nat. Nanotechnol."},{"key":"69420_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202203820","volume":"34","author":"D Tang","year":"2022","unstructured":"Tang, D. et al. Self-sacrificially degradable pseudo-semiconducting polymer nanoparticles that integrate NIR-II fluorescence bioimaging, photodynamic immunotherapy, and photo-activated chemotherapy. Adv. Mater. 34, e2203820 (2022).","journal-title":"Adv. Mater."},{"key":"69420_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/marc.202300496","volume":"44","author":"W Li","year":"2023","unstructured":"Li, W., Liang, M., Qi, J. & Ding, D. Semiconducting polymers for cancer immunotherapy. Macromol. Rapid Commun. 44, e2300496 (2023).","journal-title":"Macromol. Rapid Commun."},{"key":"69420_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41551-022-00978-z","volume":"7","author":"C Xu","year":"2023","unstructured":"Xu, C. et al. Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics. Nat. Biomed. Eng. 7, 298\u2013312 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"69420_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202310178","volume":"62","author":"S He","year":"2023","unstructured":"He, S. et al. A semiconducting iron-chelating nano-immunomodulator for specific and sensitized sono-metallo-immunotherapy of cancer. Angew. Chem. Int. Ed. Engl. 62, e202310178 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"69420_CR36","doi-asserted-by":"publisher","first-page":"7340","DOI":"10.1021\/acs.nanolett.4c01464","volume":"24","author":"F Li","year":"2024","unstructured":"Li, F. et al. Organic semiconducting sono-metallo-detonated immunobombs for ultrasensitized domestication of immunosuppressive cells. Nano Lett. 24, 7340\u20137349 (2024).","journal-title":"Nano Lett."},{"key":"69420_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46565-5","volume":"15","author":"IL Sparks","year":"2024","unstructured":"Sparks, I. L. et al. Lipoarabinomannan mediates localized cell wall integrity during division in mycobacteria. Nat. Commun. 15, 2191 (2024).","journal-title":"Nat. Commun."},{"key":"69420_CR38","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1084\/jem.20051239","volume":"202","author":"PB Kang","year":"2005","unstructured":"Kang, P. B. et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp. Med. 202, 987\u2013999 (2005).","journal-title":"J Exp. Med."},{"key":"69420_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","volume":"2","author":"MABCG Behr","year":"2002","unstructured":"Behr, M. A. B. C. G. different strains, different vaccines?. The Lancet Infect. Dis. 2, 86\u201392 (2002).","journal-title":"The Lancet Infect. Dis."},{"key":"69420_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783\u2013801 (2006).","journal-title":"Cell"},{"key":"69420_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/jid.2011.247","volume":"132","author":"R Narayan","year":"2012","unstructured":"Narayan, R. et al. Immunomodulation by imiquimod in patients with high-risk primary melanoma. J. Investig. Dermatol. 132, 163\u2013169 (2012).","journal-title":"J. Investig. Dermatol."},{"key":"69420_CR42","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1021\/acs.accounts.9b00631","volume":"53","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Small-molecule modulators of toll-like receptors. Acc. Chem. Res. 53, 1046\u20131055 (2020).","journal-title":"Acc. Chem. Res."},{"key":"69420_CR43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature09973","volume":"472","author":"AP West","year":"2011","unstructured":"West, A. P. et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472, 476\u2013480 (2011).","journal-title":"Nature"},{"key":"69420_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45058-9","volume":"15","author":"S Panda","year":"2024","unstructured":"Panda, S. et al. Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection. Nat. Commun. 15, 765 (2024).","journal-title":"Nat. Commun."},{"key":"69420_CR45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41591-022-02110-9","volume":"29","author":"M Musvosvi","year":"2023","unstructured":"Musvosvi, M. et al. T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. Nat. Med. 29, 258\u2013269 (2023).","journal-title":"Nat. Med."},{"key":"69420_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305392","volume":"11","author":"J Liang","year":"2024","unstructured":"Liang, J. et al. Engineering versatile nanomedicines for ultrasonic tumor immunotherapy. Adv. Sci. 11, e2305392 (2024).","journal-title":"Adv. Sci."},{"key":"69420_CR47","doi-asserted-by":"publisher","first-page":"2410032","DOI":"10.1002\/smll.202410032","volume":"21","author":"Z Rong","year":"2025","unstructured":"Rong, Z., Ert\u00fcrk, A., Tang, Y. & Mai, H. Tissue clearing and its application in nanoparticle development. Small 21, 2410032 (2025).","journal-title":"Small"},{"key":"69420_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep39473","volume":"6","author":"T Liu","year":"2016","unstructured":"Liu, T. et al. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Sci. Rep. 6, 39473 (2016).","journal-title":"Sci. Rep."},{"key":"69420_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SHE Kaufmann","year":"2018","unstructured":"Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S. & Bartenschlager, R. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug Discov. 17, 35\u201356 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"69420_CR50","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/cid\/ciaa470","volume":"72","author":"SM Hermans","year":"2021","unstructured":"Hermans, S. M. et al. High rates of recurrent tuberculosis disease: a population-level cohort study. Clin. Infect. Dis. 72, 1919\u20131926 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"69420_CR51","first-page":"828","volume":"11","author":"R Panjabi","year":"2007","unstructured":"Panjabi, R., Comstock, G. W. & Golub, J. E. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int. J. Tuberc. Lung Dis. 11, 828\u2013837 (2007).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"69420_CR52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1473-3099(03)00607-8","volume":"3","author":"ML Lambert","year":"2003","unstructured":"Lambert, M. L. et al. Recurrence in tuberculosis: relapse or reinfection? The Lancet Infect. Dis. 3, 282\u2013287 (2003).","journal-title":"The Lancet Infect. Dis."},{"key":"69420_CR53","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling, T. R. et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N. Engl. J. Med. 365, 2155\u20132166 (2011).","journal-title":"N. Engl. J. Med."},{"key":"69420_CR54","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","volume":"41","author":"JM Schenkel","year":"2014","unstructured":"Schenkel, J. M. & Masopust, D. Tissue-resident memory T cells. Immunity 41, 886\u2013897 (2014).","journal-title":"Immunity"},{"key":"69420_CR55","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJMra021964","volume":"349","author":"PF Barnes","year":"2003","unstructured":"Barnes, P. F. & Cave, M. D. Molecular epidemiology of tuberculosis. N. Engl. J. Med. 349, 1149\u20131156 (2003).","journal-title":"N. Engl. J. Med."},{"key":"69420_CR56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(05)70240-1","volume":"5","author":"CY Chiang","year":"2005","unstructured":"Chiang, C. Y. & Riley, L. W. Exogenous reinfection in tuberculosis. The Lancet Infect. Dis. 5, 629\u2013636 (2005).","journal-title":"The Lancet Infect. Dis."},{"key":"69420_CR57","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.cell.2024.04.027","volume":"187","author":"M Wu","year":"2024","unstructured":"Wu, M. et al. Innervation of nociceptor neurons in the spleen promotes germinal center responses and humoral immunity. Cell 187, 2935\u20132951.e19 (2024).","journal-title":"Cell"},{"key":"69420_CR58","doi-asserted-by":"publisher","first-page":"110016","DOI":"10.1016\/j.vetimm.2020.110016","volume":"221","author":"KP Lyashchenko","year":"2020","unstructured":"Lyashchenko, K. P., Vordermeier, H. M. & Waters, W. R. Memory B cells and tuberculosis. Vet. Immunol. Immunopathol. 221, 110016 (2020).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"69420_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202402103","volume":"13","author":"Z Hu","year":"2024","unstructured":"Hu, Z. et al. Extracellular vesicle-inspired therapeutic strategies for the COVID-19. Adv. Healthc. Mater. 13, e2402103 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"69420_CR60","doi-asserted-by":"crossref","unstructured":"Wang, W. et al. Antibiotic-loaded lactoferrin nanoparticles as a platform for enhanced infection therapy through targeted elimination of intracellular bacteria. Asian J. Pharm. Sci. 19, 100926 (2024).","DOI":"10.1016\/j.ajps.2024.100926"},{"key":"69420_CR61","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ni.3434","volume":"17","author":"M Ouimet","year":"2016","unstructured":"Ouimet, M. et al. Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism. Nat. Immunol. 17, 677\u2013686 (2016).","journal-title":"Nat. Immunol."},{"key":"69420_CR62","first-page":"111","volume":"5","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Ultrastable in-situ silver nanoparticle dressing for effective prevention and treatment of wound infection in emergency. Eng. Regener. 5, 111\u2013123 (2024).","journal-title":"Eng. Regener."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69420-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:02:32Z","timestamp":1773932552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69420-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69420"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69420-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2595"}}